Melanoma during fingolimod treatment for multiple sclerosis

Autor:	C. Lubetzki, M. Thomas, Andrea Cavalcanti, C. Velter, F. Chochon, Emilie Routier, Caroline Robert, M. Bastien
Rok vydání:	2019
Předmět:	Oncology Cancer Research medicine.medical_specialty Side effect business.industry Multiple sclerosis Melanoma medicine.disease Fingolimod Internal medicine medicine Adverse effect business medicine.drug
Zdroj:	European Journal of Cancer. 113:75-77
ISSN:	0959-8049
DOI:	10.1016/j.ejca.2019.03.011
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::002b3c16a58633010a05d0c414811ad2 https://doi.org/10.1016/j.ejca.2019.03.011 Zobrazit plný text záznamu Full Text from ScienceDirect